No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Aurora B Kinase market is a subset of the larger drug discovery market. It is focused on the development of drugs that target the Aurora B Kinase enzyme, which is involved in cell division and is often mutated in cancer cells. Aurora B Kinase inhibitors are being studied as potential treatments for a variety of cancers, including breast, ovarian, and colorectal cancer.
The Aurora B Kinase market is highly competitive, with many companies developing drugs that target the enzyme. Companies in the market include AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
